Unusual bleeding is the main symptom in 90% of women with endometrial cancer. However, endometrial cancer can be determined as the cause in only 3% of peri- and postmenopausal cases of bleeding. The current S3 Guideline recommends subjective procedures such as clinical examinations, cytology, and transvaginal ultrasounds for the differential diagnosis of endometrial cancers with unusual bleeding. Transvaginal ultrasound has a very low positive predictive value of 4.9%. As a result, most women who undergo a surgical diagnostic procedure do not actually have endometrial cancer.
The WID®-easy test offers the possibility of improving this situation and very quickly arriving at a diagnosis. The test demonstrates sensitivity comparable to that of transvaginal ultrasound, but reduces the rate of false positive results by 94%.
